Disinfecting luer cap and method of use

Information

  • Patent Grant
  • 11752318
  • Patent Number
    11,752,318
  • Date Filed
    Tuesday, March 31, 2020
    4 years ago
  • Date Issued
    Tuesday, September 12, 2023
    a year ago
Abstract
Medical devices including a cap for a medical connector are disclosed. In some embodiments, the cap comprises a disinfectant, such as an antiseptic fluid and an insert configured to seal or partially seal the medical connector as it is engaged with the cap. In some embodiments the cap insert has a segment which is deformable under axially applied pressure as an end-user attaches the cap to the medical connector. In some embodiments this insert is configured to improve the exposure of antiseptic to the outer surface of the medical connector while minimizing exposure of the antiseptic inside the medical connector open lumen.
Description
TECHNICAL FIELD

The field of the present disclosure relates generally to medical devices. More specifically, the present disclosure relates to caps for medical connectors. In some embodiments, the present disclosure relates to caps that can be used to protect the sterility of open medical connectors.





BRIEF DESCRIPTION OF THE DRAWINGS

The embodiments disclosed herein will become more fully apparent from the following description and appended claims, taken in conjunction with the accompanying drawings. The drawings depict only typical embodiments, which embodiments will be described with additional specificity and detail in connection with the drawings in which:



FIG. 1 depicts a simplified exploded view of certain components of a medical connector cap.



FIG. 2A depicts a simplified end view of certain components of a medical connector cap.



FIG. 2B depicts a simplified cross-section view of certain components of the medical connector cap of FIG. 2A, taken through plane A-A.



FIG. 3A depicts a simplified perspective view of a medical connector.



FIG. 3B depicts a simplified perspective view of another embodiment of a medical connector.



FIG. 4A depicts a simplified cross-section view of certain components of a medical connector cap engaging with certain components of a medical connector, in a first configuration.



FIG. 4B depicts a simplified cross-section view of certain components of the medical connector cap and medical connector of FIG. 4A in a second configuration.



FIG. 5 depicts a simplified side view of a portion of a medical connector cap.



FIG. 6 depicts a simplified side view of a portion of another embodiment of a medical connector cap.



FIG. 7 depicts a simplified perspective view of a portion of another embodiment of a medical connector cap.



FIG. 8A depicts a simplified exploded view of certain components of a medical connector cap.



FIG. 8B depicts a simplified side view of certain components of a medical connector cap.



FIG. 8C depicts a simplified cross-section view of certain components of the medical connector cap of FIG. 8B taken through plane 8C.



FIG. 9A depicts a simplified cross-section view of certain components of a female luer connector.



FIG. 9B depicts a simplified cross-section view of certain components of a medical connector cap engaged with a female luer connector.



FIG. 9C depicts a simplified cross-section view of certain components of a female luer connector.





DETAILED DESCRIPTION

Patients undergoing various treatments may receive a central vascular catheter. Exposure of such catheters to foreign bodies increases the risk of catheter-related bloodstream infections. Infections associated with central venous catheters are categorized as either central-line associated bloodstream infections or catheter-related bloodstream infections. These infections can increase hospital costs and length of stay. The costs to hospitals and the health care system from these infections are substantial in terms of both morbidity and resources expended.


In the detailed description, reference is made to the accompanying drawings which form a part hereof and in which are shown, by way of illustration, specific embodiments of the disclosure. These embodiments are described in sufficient detail to enable those of ordinary skill in the art having the benefit of this disclosure to practice the present disclosure, and it is to be understood that other embodiments may be utilized, and that structural, logical, and electrical changes may be made within the scope of the disclosure. From the following descriptions, it should be understood that components of the embodiments as generally described and illustrated in the figures herein could be arranged and designed in a wide variety of different configurations. Thus, the following more detailed description of various embodiments, as represented in the figures, is not intended to limit the scope of the disclosure, but is merely representative of various embodiments. While the various aspects of the embodiments are presented in drawings, the drawings are not necessarily drawn to scale unless specifically indicated.


In this description, specific implementations are shown and described only as examples and should not be construed as the only way to implement the present disclosure unless specified otherwise herein. It will be readily apparent to one of ordinary skill in the art having the benefit of this disclosure, for example, that the various embodiments of the present disclosure may be practiced with numerous types and forms of medical connectors. The devices and methods described herein could be useful in a number of environments that employ conduits or connectors, for example, the present disclosure may be practiced in any situation that uses at least one connector with a luer end.


It should be understood that any reference to an element herein using a designation such as “first,” “second,” and so forth does not limit the quantity or order of those elements, unless such limitation is explicitly stated. Rather, these designations may be used herein as a convenient method of distinguishing between two or more elements or instances of an element. Thus, a reference to first and second elements does not mean that only two elements may be employed there or that the first element must precede the second element in some manner. Also, unless stated otherwise a set of elements may comprise one or more elements.


The phrases “connected to” and “coupled to” refer to any form of interaction between two or more entities, including mechanical, electrical, magnetic, electromagnetic, fluid, and thermal interaction. Two components may be connected or coupled to each other even though they are not in direct contact with each other. For example, two components may be coupled to each other through an intermediate component.


The directional terms “proximal” and “distal” are used herein to refer to opposite locations on a medical device. The proximal end of the device is defined as the end of the device closest to the end-user when the device is in use by the end-user. The distal end is the end opposite the proximal end, along the longitudinal direction of the device, or the end furthest from the end-user.


Referring in general to the following description and accompanying drawings, various embodiments of the present disclosure are illustrated to show its structure and method of operation. Common elements of the illustrated embodiments may be designated with similar reference numerals. Accordingly, the relevant descriptions of such features apply equally to the features and related components among all the drawings. Any suitable combination of the features, and variations of the same, described with components illustrated in FIG. 1, can be employed with the components of FIG. 2, and vice versa. This pattern of disclosure applies equally to further embodiments depicted in subsequent figures and described hereinafter. The figures presented are not meant to be illustrative of actual views of any particular portion of the actual structure or method, but are merely idealized representations employed to more clearly and fully depict the present disclosure defined by the claims below.


One embodiment of the present disclosure comprises a cap for a medical connector. The medical connector may have a luer connector. The cap may further comprise a disinfecting agent. In some embodiments the cap comprises a chamber containing the disinfecting agent. When an end-user attaches the cap comprising the disinfecting agent to the luer connector it applies the disinfectant to the open end of the luer connector. The open end of the cap is configured to connect to a medical connector such as a luer connector. In some embodiments the cap is configured to engage with a female luer connector, and in other embodiments the cap is configured to a male luer connector. For example, the cap may be configured with threads to engage a medical connector such as a male or female luer connector. In some embodiments these threads are configured with a hard stop to prevent an end-user from over rotating the cap. Additionally or alternatively, the threads may be configured to provide sufficient rotation of the cap with respect to a connector to dispense an adequate amount of antiseptic fluid to provide effective disinfection.


The cap may comprise a chamber which has a chamber inner lumen. Within the cap chamber the cap may further comprise a reservoir and an insert. The insert is disposed in the chamber lumen and comprises a first end which is shaped to engage with the open end of a medical connector such as a luer connector. This shape may be dome shaped, a frusto-conical shape, or any other shape which may seal or partially seal the open end of a medical connector to reduce fluid entering the lumen of the medical connector while maximizing the flow of fluid around the insert and the outer surfaces of the medical connector.


In some embodiments the cap is configured to facilitate alignment of the insert with the open end of a medical connector. For example, the insert may be disposed within the cap such that threads of the cap tend to align the insert and a medical connector during coupling of the cap and medical connector. The insert may thus tend to engage flush with the open end of a luer connector. In some embodiments the insert may engage substantially perpendicular to the open end of the luer so that the entire circumference of the open end of the luer connector engages substantially simultaneously with the insert. Engaging substantially simultaneously around the entire circumference of the open end of the luer connector may, in turn, reduce or minimize an antiseptic fluid from flowing into the inner luminal space of the luer connector when it engages with the cap.


The insert may also comprise an annular gap that allows an antiseptic fluid to flow around the insert and interact with the surface of the dome shaped first end of the insert during coupling of a cap and a medical connector. As the cap engages with the medical connector radial expansion of the insert may tend to reduce or eliminates this gap reducing or eliminating the amount of antiseptic fluid which can flow around the insert and interact with the medical connector.


Some caps within the scope of this disclosure may be configured to hold 45 pounds per square inch (PSI) of pressure.


The insert may further comprise a second end which is configured to deform when an end-user, such as a health care worker, engages the cap onto a medical connector. As the medical connector, such as the luer connector, is engaged with the cap the open end of the luer connector exerts axial force against the insert. In some embodiments, the insert second end deforms radially as the insert moves axially. The inner walls of the cap chamber may limit the degree the insert second end is able to deform under this axial force. In some embodiments, when the end-user disengages the cap from the luer connector, the insert second end begins to assume its original shape. In this way the insert may move like a spring axially within the cap chamber. When the insert springs back into its original shape it may thus maintain an axial force against the luer connector open end until the luer connector fully disengages from the cap. As the cap is disengaged in this manner the seal or partial seal is maintained between the insert first end and the open end of the luer connector, minimizing the amount of fluid that is able to enter the open end of the luer connector. This second end of the insert may be thought of as a controlled-deformation segment and serves to provide axial force against the medical connector which has been engaged with the cap. In some embodiments the insert second end may comprise external ribs that contact protrusions on the internal sidewall of the cap chamber. The cap is reusable, for example, configured with an insert that is able to deform and spring back into its original shape multiple times, or the cap may be configured as a single use device. The cap second end is further configured to be grasped comfortably and securely by an end-user, such as a health care worker.


In some embodiments the cap chamber further comprises a reservoir configured to absorb fluid, such as disinfectant antiseptic fluid. In some embodiments the reservoir is polyester urethane foam. In some embodiments the polyester urethane foam has a density of between 0.5 and 4 lbs/ft3. In some embodiments the polyester urethane foam has a density of between 1 and 3 lbs/ft3. In some embodiments the polyester urethane foam has a density of 2 lbs/ft3. In some embodiments the reservoir surrounds the insert. In alternative embodiments the reservoir is in a hollow portion of the insert. In some embodiments the reservoir is axially distal to the insert, in other words further from the open cap first end. In some embodiments the reservoir is axially proximal to the insert, in other words closer to the open cap first end. In some embodiments the reservoir is in contact with the insert first end. In some embodiments the reservoir is in contact with the insert second end.


Various materials are within the scope of this disclosure. For example, the insert may be comprised of various polymeric and/or elastomeric materials, including silicones, isoprene, neoprene, Santoprene, and so forth. The reservoir may comprise various foam materials, including polyester urethane foam as discussed above. The reservoir may also comprise an elastomeric material, including elastomers including pores or other structures capable of absorbing a liquid antiseptic agent. The reservoir may be a non-particulate elastomer configured to reduce or minimize breakdown of the reservoir that may result in particles within the cap or connector. Embodiments wherein the insert comprises a hollow portion or void with no separate component was a reservoir (such as embodiments wherein a void within an elastomeric insert is configured to act as a reservoir for an antiseptic fluid) are also within the scope of this disclosure.


The cap chamber may contain a disinfectant, such as an antiseptic. In some embodiments this antiseptic may be an antiseptic fluid such as isopropyl alcohol, hydrogen peroxide, chlorhexidine gluconate, iodophor, povidone iodine, or any other suitable antiseptic. In some embodiments the antiseptic is not fluid but in the form of disinfectant beads, such as hydrogel beads, disinfectant foam, or a loaded polymer. In some embodiments the antiseptic is sequestered in the cap chamber within a first closed compartment by a breakable seal, such as a foil seal. This foil seal will stay intact until an end-user engages the cap with a medical connector which then may exert axial pressure on the cap insert. Alternatively, a foil seal may be disposed across the cap chamber such that an end-user can peel off or otherwise remove the foil seal prior to use. The cap insert may then deform, exerting radial force which can then break the seal holding the antiseptic, releasing it into the cap chamber. In this way, the antiseptic is released and surrounds the insert and the outer surfaces of the medical connector while minimizing the amount of antiseptic that enters the luer connector open end which is loosely sealed by the cap insert first end. In some embodiments the antiseptic is soaked into the reservoir, and when the cap insert is pushed axially it compresses the reservoir, releasing the antiseptic into the chamber and similarly surrounding the insert and the outer surfaces of the medical connector. In some embodiments the antiseptic fluid is both in an absorbent reservoir and sequestered in a breakable seal within the cap chamber inner lumen.


In some embodiments when the end-user disengages the cap from the medical connector, the insert returns to its original shape, which increases the volume within the cap chamber. As the insert returns to its original shape the reservoir will expand, increasing the volume of fluid, such as antiseptic fluid, the reservoir can hold. As the reservoir expands it creates a vacuum or partial vacuum acting on the fluid, thus tending to draw in and absorb the fluid which had been surrounding the insert and the outer surfaces of the medical connector. In this way as the cap is disengaged from the medical connector the amount of fluid in contact with the outer surface of the medical connector decreases, which serves to further reduce the amount of fluid that enters the open end of the medical connector as it is fully disengaged from the cap and the insert first end.


In some embodiments the cap insert may be configured to store the antiseptic within the insert. For example, the insert may be hollow with side apertures to permit the antiseptic agent to flow out of the insert when axial force is exerted on the insert from the end-user attaching a medical connector to the cap. In some embodiments the insert first end may inhibit flow of fluid, such as an antiseptic fluid into the lumen of an engaged medical connector while allowing flow to specific regions on or in the medical connector. In some embodiments the insert is made of a single material. In alternative embodiments the insert first end is made of material different from the insert second end. In some embodiments the insert first end is reinforced to reduce deformation when axial force is applied to the insert when an end-user attaches a medical connector to the cap. In some embodiments the cap is configured with radial protrusions to maintain the insert in the cap chamber.


In some embodiments the method of capping a medical connector with a cap, as described above, is disclosed herein. The end-user may obtain a cap, as described above. If a foil seal is present, the end-user may peels off a foil seal from an end of the cap to open the cap chamber. The end-user may then connect the cap to the open end of the medical connect and twist either the cap to fully engage the cap on the connector or the connector to fully engage the cap. The cap will then disinfect, as described above, the outer surface of the medical connector while minimizing the amount of disinfectant that enters the open end of the medical connector. In some embodiments the cap may be configured with threading to engage the medical connector. In some embodiments these threads, or an end of these threads, are configured with a hard stop to prevent the end-user from over rotating the cap on the medical connector. In some embodiments the cap is configured to engage with a female luer connector. In alternative embodiments the cap is configured to engage with a male luer connector. In some embodiments the end of the cap is sealed with a sterile seal which is removable by the end-user just before it is attached to the medical connector.


In some embodiments the means for minimizing medical connector infections is provided by applying a cap, as described above, to a medical connector. The cap applies an antiseptic agent to a medical connector. In some embodiments, the cap has engagement means to attach to a male luer connector. In some embodiments, the cap comprises the means for limiting or minimizing the flow of antiseptic in the cap chamber as the end-user engages the open end of a medical connector with the cap, while at the same time maximizing the flow of antiseptic to the outer surface of the medical connector. In some embodiments the cap comprises an insert in the chamber, the insert comprising the means to exert axial force against the open end of the medical connector as the cap is both engaged and disengaged with the medical connector. In some embodiments the cap is configured with a means of maintaining the insert in the cap chamber.



FIG. 1 depicts a simplified exploded view of various components of a medical connector cap 100. The cap 100 has a cap first end 116 which comprises an opening 114 and a second end 122 configured to be grasped securely and comfortably by an end-user. A cap body 120 is between the cap first end 116 and the second end 122. In the illustrated embodiment, the cap first end 116 is configured to be attached to a male luer connector and further comprises ridges 118 which serve as threads to engage the male luer connector. The cap 100 comprises an insert 102 and a reservoir 112. The insert 102 comprises an insert first end 104 configured to engage and seal or partially seal the open end of a male luer connector. In some embodiments, the insert first end 104 of the insert 102 may comprise a shape configured to seal or partially seal against a portion of a connector, such as a luer connector. For example, in the illustrated embodiment, the insert first end 104 of the insert 102 comprises a dome or curved shape, configured to seal or partially seal against a luer connector. As also described above, other shapes, such as frusto-conical shapes, are within the scope of this disclosure. Further, the insert first end 104 of the insert 102 may be configured to partially conform to the shape of a portion of the luer to facilitate sealing. In some embodiments the insert 102 is disposed within the cap 100 such that the ridges 118, in threaded engagement with the luer, tend to align the cap 100 and the luer before the insert first end 104 engages the luer. Thus, the cap 100 may be configured such that the insert first end 104 is substantially perpendicular to the open end of the luer (not depicted) during coupling of the cap 100 and a luer. In some embodiments insert reinforcements 106 are configured to align or maintain the alignment of the insert first end 104 within (and with respect to) the cap 100.


The insert 102 also comprises an insert body 108 between the insert first end 104 and an insert second end 110. In this embodiment the insert second end 110 is configured to deform under axially applied pressure. In this embodiment the insert first end 104 is reinforced with the insert reinforcement 106 to reduce deformation of the insert first end 104 and the insert body 108 under axially applied pressure. In the depicted embodiment, the reservoir 112 comprises a reservoir hole 113 through which the insert second end 110 and the insert body 108 may be pushed. The insert first end 104 further serves to limit the distance the insert 102 can be pushed through the reservoir hole 113. The insert reinforcement 106 may in some embodiments be configured to further limit the position the insert 102 takes within the reservoir 112.



FIG. 2A depicts an end view of another embodiment of a cap 200 that resembles the cap 100 described above in certain respects. Accordingly, like features are designated with like reference numerals, with the leading digits incremented to “2.” For example, the embodiment depicted in FIGS. 2A-2B includes a cap body 220 that may, in some respects, resemble the cap body 120 of FIG. 1. Relevant disclosure set forth above regarding similarly identified features thus may not be repeated hereafter. Moreover, specific features of the cap 200 and related components shown in FIGS. 2A-2B may not be shown or identified by a reference numeral in the drawings or specifically discussed in the written description that follows. However, such features may clearly be the same, or substantially the same, as features depicted in other embodiments and/or described with respect to such embodiments. Accordingly, the relevant descriptions of such features apply equally to the features of the cap 200 and related components depicted in FIGS. 2A-2B. Any suitable combination of the features, and variations of the same, described with respect to the cap 100 and related components illustrated in FIG. 1 can be employed with the cap 200 and related components of FIGS. 2A-2B, and vice versa. This pattern of disclosure applies equally to further embodiments depicted in subsequent figures and described hereafter, wherein the leading digits may be further incremented.


The cap 200 comprises the cap body 220 and a cap first end 216. The cap first end 216 comprises a cap opening 214. The cap first end 216 is further configured to engage a male luer connector with threads 218. An insert first end 204 is visible through the cap opening 214. FIG. 2A also indicates plane A-A through which a cross-section of the cap 200 is taken and shown in FIG. 2B.


As noted above, FIG. 2B depicts a cross-section view of the cap 200 through plane A-A of FIG. 2A. With reference to FIGS. 2A-2B, the cap 200 illustrated therein comprises the cap first end 216, the cap body 220, and a cap second end 222. The cap first end 216 comprises protrusions 218 which serve as threading to engage with a male luer connector. The cap first end 216 further comprises the cap opening 214. The cap 200 also comprises a cap chamber 224. In the illustrated embodiment, the cap chamber 224 comprises an inner lumen which contains an insert 202 and a reservoir 212. The insert 202 comprises the insert first end 204 configured to engage with the open end of a medical connector. The insert 202 further comprises an insert body 208 and an insert second end 210. The insert body 208 comprises an insert reinforcement 206 to reduce deformation of the insert 202 under axially applied pressure. The insert second end 210 is configured to deform under axially applied pressure. In this embodiment the insert second end 210 comprises two prongs which will bow outward radially until they come into contact with the cap chamber's 224 inner walls.



FIGS. 3A and 3B depict two examples of medical connectors. FIG. 3A depicts a perspective view of a medical connector hub 330. The hub 330 has both a male luer connector 338 and two female luer connectors 332. The female luer connector 332 comprises a first end 336 and an opening 334. The male luer connector 338 comprises a threaded engagement member 342, a male luer connector body 340, and a male luer connector first end 344. The male luer connector first end 344 comprises a male luer opening 346. FIG. 3B depicts a medical connector 350 which comprises a female luer connector 352 with a first end 356. The female luer connector 352 first end 356 comprises a first opening 354.



FIGS. 4A and 4B depict cross-section views of a cap 400 engaging a male luer connector end 438, in first and second configurations, respectively. The medical connector such as the male luer connector end 438 is inserted so that a male luer connector body 440 is inserted into a cap opening 414. The end-user will slide the male luer connector body 440 into the cap opening 414 until a male luer open end 444 comes into contact with an insert first end 404. A male luer threaded engagement member 442 slides around a cap first end 416 to begin to engage with cap protrusions 418 which serve as threading. An insert reinforcement 406 and insert body 408 as well as a cap body 420 and cap second end 422 are also indicated in the figures.


In the first configuration, shown in FIG. 4A, the end-user has not yet exerted enough axial force on an insert 402 to push it axially into a cap chamber 424 enough to deform an insert second end 410. In the second configuration, shown in FIG. 4B, the end-user has exerted enough axial force on the insert 402 to deform the insert second end 410. The male luer threaded engagement member 442 is thus in position to engage the threading via the cap protrusions 418 and further tighten the cap 400 onto the male luer connector end 438 which will exert additional axial force on the insert 402. As the insert 402 is forced down into the cap chamber 424 the insert second end 410 deforms, which may result in the decrease of the cap chamber 424 available volume and the compression of a reservoir 412. An antiseptic (not depicted) may then be forced out of the reservoir 412 (for example due to the decrease in the volume of the reservoir 412) into this remaining cap chamber 424 volume and would be exposed to the outer surface of the male luer open end 444 and the male luer connector body 440. As the male luer connector end 438 is further tightened onto the cap 400 it may be configured to limit the amount of antiseptic which spills outside of the cap opening 414. In other words, the reservoir 412 may act like a sponge, absorbing antiseptic liquid when the reservoir 412 is uncompressed and releasing antiseptic liquid into the cap chamber 424 as the reservoir 412 is compressed. Backing the cap 400 off the luer may allow the reservoir to return to an uncompressed configuration and reabsorb liquid antiseptic disposed in the cap chamber 424.



FIG. 5 depicts a side view of a cap insert 502. The insert 502 comprises an insert first end 504 configured and shaped to engage and seal or partially seal a medical connector open end. The insert 502 further comprises a reinforcement 506 configured to reduce deformation of the insert 502 near the insert first end 504. An insert second end 510 is configured to deform under axially applied pressure. The insert 502 of FIG. 5 is shown in a generally uncompressed configuration.



FIG. 6 depicts a side view of a cap insert 602 shown after axially applied pressure has deformed an insert second end 610. In other words, as compared to the uncompressed configuration of the insert 502 of FIG. 5, FIG. 6 illustrates an analogous insert 602 in a compressed configuration. An insert first end 604 remains in its original shape and thus resists angular misalignment of the insert first end 604. The insert first end 604 is reinforced with an insert reinforcement 606. In other embodiments the insert first end 604 resists deforming under axially applied pressure while the insert second end 610 deforms because the insert first end 604 is made up of more rigid material than the insert second end 610.



FIG. 7 depicts a perspective view of one embodiment of a reservoir 712. This embodiment of the reservoir 712 is a cube, and the reservoir 712 comprises an opening 713 through which an insert, such as the insert 502, may be placed.



FIG. 8A depicts a simplified exploded view of various components of a medical connector cap 800. The cap 800 has a cap first end 816 which comprises a cap opening 814 and a cap second end 822 configured to be grasped by an end-user. A cap body 820 is between the cap first end 816 and the cap second end 822. In the illustrated embodiment, the cap first end 816 is configured to be attached to a female luer connector and further comprises ridges 818 which serve as threads to engage the female luer connector. The cap 800 comprises an insert 802 and a reservoir 812. The insert 802 comprises an insert first end 804 configured to engage and seal or partially seal the open end of a female luer connector (not depicted).


The insert first end 804 of the insert 802 may be dome shaped, with a hemispherical shape to engage and seal or partially seal the open end of a female luer connector (not depicted). Additionally or alternatively, the insert first end 804 of the insert 802 may be configured to partially conform to the shape of a portion of the luer to facilitate sealing. In some embodiments the insert 802 is disposed within the cap 800 such that the ridges 818, in threaded engagement with a luer, tend to align the insert 802 and the luer before the insert first end 804 of the insert 802 engages the open end of the luer. Additionally, in some embodiments the insert 802 comprises an insert second end 810 which is open and configured to accept a reservoir such as the reservoir 812 within the insert 802.


In some embodiments, the cap 800 is configured such that there is an annular gap 805 between the insert 802 and the cap 800 when the insert 802 is unconstrained. This annular gap 805 may allow an antiseptic fluid to flow around the insert 802, for example, from the reservoir 812 adjacent the insert second end 810 of the insert 802. Thus, the annular gap 805 may allow antiseptic fluid from the reservoir 812 to interact with the insert first end 804 and then come into contact with the luer end (not depicted) during coupling of a luer and the cap 800. In some embodiments when the luer cap is partially or fully engaged with the cap 800 a compressive force exerted on the insert 802 by the luer may cause the insert 802 to radially expand, thus reducing or closing the annular gap 805. This, in turn, may reduce or eliminate the antiseptic fluid flow around the insert 802, which may limit excess antiseptic fluid from entering the luer end.



FIG. 8B depicts a side view of the cap 800. The cap 800 comprises the cap body 820 and the cap first end 816. The cap first end 816 comprises an opening (not depicted). The cap first end 816 may be configured to engage a luer or other medical connector. The cap second end 822 may be configured to be grasped by an end-user. Line 8C of FIG. 8B indicates the plane of the cross-section depicted in FIG. 8C.



FIG. 8C depicts a cross-section of the cap 800. The cap body 820 and cap first end 816 and indicated in this figure. In the illustrated embodiment, the cap first end 816 comprises the cap opening 814. Further, the ridges 818 within the cap opening 814 may be configured as threads for engagement with a luer connector (not depicted).


As shown in FIG. 8C, the cap 800 may also comprise the cap chamber 824. The cap chamber 824 defines an inner lumen which contains the insert 802 and the reservoir 812. Again, the first end 804 of the insert 802 is positioned and configured to engage with the open end of a medical connector such as a luer when the cap 800 is coupled to a medical connector. The insert second end 810 of the insert 802 may be configured to accommodate the reservoir 812 inside, or partially inside, the insert 802. As noted above, the insert 802 and cap 800 may define the annular gap 805. In some embodiments an antiseptic fluid (not depicted) is disposed within the cap chamber 824. The reservoir 812 may absorb some or all of the antiseptic fluid.



FIGS. 9A-9C depict a female luer connector 932 being connected to a cap body 920. FIG. 9A depicts a cross-section of the luer connector 932 with a female luer connector first end 936 comprising an opening 934. FIG. 9B depicts the cap body 920 engaging with the luer connector 932. A first cap end 916 of the cap body 920 comprises an opening 914 into which the luer connector 932 can be engaged. Ridges 918 disposed within the opening 914 are configured as threads to engage the female luer connector first end 936. In the illustrated embodiment, an insert 902 has a dome shaped first end 904 which is configured to engage with the female luer connector first end 936. An annular gap 905 is disposed between the insert 902 and the cap body 920. The insert 902 may also partially receive and/or surround a reservoir 912. As further detailed in Example 1, below, FIGS. 9A-9B also depict the deposition of a tungsten powder 970 on an inner luminal surface 935 of the female luer connector first end 936 and around the circumference of the opening 934.



FIG. 9C depicts a cross-section of the female luer connector first end 936 after it has been disengaged from a cap 900, according to the procedure outlined in Example 1. As compared to the connector as depicted in FIGS. 9A-9B, the tungsten powder 970 generally remains on the inner luminal surface 935 after disengagement of the female luer connector first end 936 from the cap 900. As illustrated in FIG. 9C, in some instances the tungsten powder 970 may be displaced by the first end 904 of the insert 902 when coupled as shown in FIG. 9B. As explained in Example 1, the position of the tungsten powder 970 in FIG. 9C illustrates how the insert 902 and reservoir 912 may limit ingress of antiseptic fluid into the female luer connector first end 936.


Kits that include a medical connector cap are also within the scope of this disclosure. For example, a kit may include any of the devices described above. The kit may also include other elements, such as instructions for using the devices. Kits may additionally or alternatively include (1) male luer connector caps; (2) female luer connector caps; (3) double-ended luer connector caps; (4) sterile gloves; (5) sterile barrier; (6) antiseptic swabs; and (7) sterile gauze, among other potential elements.


Any methods disclosed herein include one or more steps or actions for performing the described method. The method steps and/or actions may be interchanged with one another. In other words, unless a specific order of steps or actions is required for proper operation of the embodiment, the order and/or use of specific steps and/or actions may be modified. Moreover, sub-routines or only a portion of a method described herein may be a separate method within the scope of this disclosure. Stated otherwise, some methods may include only a portion of the steps described in a more detailed method.


Reference throughout this specification to “an embodiment” or “the embodiment” means that a particular feature, structure, or characteristic described in connection with that embodiment is included in at least one embodiment. Thus, the quoted phrases, or variations thereof, as recited throughout this specification are not necessarily all referring to the same embodiment.


Similarly, it should be appreciated by one of skill in the art with the benefit of this disclosure that in the above description of embodiments, various features are sometimes grouped together in a single embodiment, figure, or description thereof for the purpose of streamlining the disclosure. This method of disclosure, however, is not to be interpreted as reflecting an intention that any claim requires more features than those expressly recited in that claim. Rather, as the following claims reflect, inventive aspects lie in a combination of fewer than all features of any single foregoing disclosed embodiment. Thus, the claims following this Detailed Description are hereby expressly incorporated into this Detailed Description, with each claim standing on its own as a separate embodiment. This disclosure includes all permutations of the independent claims with their dependent claims.


Recitation in the claims of the term “first” with respect to a feature or element does not necessarily imply the existence of a second or additional such feature or element. It will be apparent to those having skill in the art that changes may be made to the details of the above-described embodiments without departing from the underlying principles of the present disclosure.


While the disclosure is susceptible to various modifications and implementation in alternative forms, specific embodiments have been shown by way of non-limiting example in the drawings and have been described in detail herein. However, it should be understood that the disclosure is not intended to be limited to the particular forms disclosed. Rather, the disclosure includes all modifications, equivalents, and alternatives falling within the scope of the disclosure as defined by the following appended claims and their legal equivalents.


Without further elaboration, it is believed that one skilled in the art can use the preceding description to utilize the present disclosure to its fullest extent. The examples and embodiments disclosed herein are to be construed as merely illustrative and exemplary and not a limitation of the scope of the present disclosure in any way. It will be apparent to those having skill in the art, and having the benefit of this disclosure, that changes may be made to the details of the above-described embodiments without departing from the underlying principles of the disclosure herein.


Example 1

Disinfecting caps for open female connectors were tested with stopcock connectors to observe alcohol ingress into the lumen of the stopcock connector. Testing did not show alcohol ingress but reflected evidence of the insert protruding for up to 1 mm into the lumen of the connector. As discussed above, FIGS. 9A-9C schematically illustrate the components of this Example. Three luer connector/cap assemblies were tested. For this example, the inserts 902 were made from Santoprene 8281-55MED. The reservoir 912 was composed of polyester urethane foam measuring 0.2 inches in diameter and having a height of 0.3 inches. 175 μl of 70% isopropyl alcohol was dispensed into the cap 900, and the insert 902/reservoir 912 assembly was inserted into the cap 900. The resulting assembly was analogous to the assembly of the embodiment shown in FIG. 8C.


A layer of the tungsten powder 970 was dusted into the inner luminal surface 935 of the luer connector 932 to act as the contrast agent, as the tungsten powder 970 would get disrupted when it encountered alcohol during testing of coupling and uncoupling of the luer connector 932 and the cap 900.


Luer connectors 932 dusted with a tungsten powder 970 (in the configuration shown in FIG. 9A) were mounted onto a luer post and placed in a 3D CT scanner for imaging. The luer connectors 932 were then assembled with the caps 900 as shown in FIG. 9B and exposed to x-rays which was then followed by disassembly and a last round of imaging.


The caps 900 were found to maintain contact with the opening 934 of the luer connector 932 as the insert 902 in the cap 900 deformed to maintain pressure at the insert 902—the opening 934 interface. This seal prevented alcohol from contact with the inner luminal surface 935 of the luer connector 932. Tungsten particles were observed to be displaced (as shown in FIG. 9C) around the circumference of the opening 934. This displacement can be attributed to the physical disturbance caused by the insert 902 that protruding into luer connector 932 to prevent alcohol ingress.

Claims
  • 1. A cap for a medical connector, the cap comprising: a first end comprising an opening configured to connect a medical connector; a chamber disposed in the cap; andan insert disposed at least partially in the chamber with a first end and a second end, wherein the second end is configured to engage with the chamber and deform during use and at least partially return back to its original shape during use.
  • 2. The cap of claim 1, wherein the first end of the insert comprises a dome shape.
  • 3. The cap of claim 1, further comprising a compressible reservoir disposed at least partially within the chamber.
  • 4. The cap of claim 3, further comprising an annular gap between the insert and an inner wall of the chamber when the insert is unconstrained, wherein the annular gap allows antiseptic fluid to flow around the insert from the reservoir to interact with a luer end of the medical connector.
  • 5. The cap of claim 1, wherein the second end of the insert comprises an opening.
  • 6. The cap of claim 4, further comprising a chamber disposed within the insert, wherein the chamber of the insert partially extends from the opening of the insert toward the first end of the insert.
  • 7. The cap of claim 6, further comprising a compressible reservoir that is at least partially disposed within the chamber of the insert.
  • 8. The cap of claim 6, wherein the chamber disposer within the insert has a cylindrical shape.
  • 9. The cap of claim 1, wherein an outer surface of the insert comprises a plurality of annular grooves that are longitudinally space apart.
  • 10. The cap of claim 1, wherein the second end of the insert comprises an annular protrusion that defines a cylindrical chamber disposed within the insert and comprises an open end.
  • 11. The cap of claim 10, wherein an outer surface of the annular protrusion comprises a plurality of annular grooves that are longitudinally spaced apart.
  • 12. A cap for a medical connector, the cap comprising: a cap body comprising an opening on a first end configured to connected to a medical connector;a chamber disposed in the cap that extends from the opening to chamber surface parallel to the opening;an insert with a first end and a second end, wherein the insert is disposed at least partially in the chamber and the second end of the insert is configured to engage with the chamber surface, andan annular gap between the insert and an inner wall of the chamber when the insert is unconstrained,wherein the medical connector is configured to apply a compressive force to the first end of the insert and deforms the second end of the insert and radially expands the insert.
  • 13. The cap of claim 12, wherein the annular gap is reduced or closed when the compressive force is applied to the insert and the insert radially expands.
  • 14. The cap of claim 12, wherein the first end of the insert comprises a dome shape.
  • 15. The cap of claim 12, further comprising a compressible reservoir disposed at least partially within the chamber between the first end of the insert and the chamber surface.
  • 16. The cap of claim 15, further comprising an antiseptic that disposed in the compressible reservoir that releases the antiseptic when the reservoir is compressed.
  • 17. The cap of claim 16, wherein the first end of the insert is configured to limit fluid flow into a connector lumen of the medical connector when the first end of the insert is in contact with the medical connector.
  • 18. The cap of claim 12, wherein the first end of the insert is reinforced to limit deformation of the insert first end.
  • 19. The cap of claim 12, wherein the second end of the insert is configured to at least partially return back to its original shape during use.
RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/874,505, filed on Jan. 18, 2018 and titled, “Disinfecting Luer Cap and Method of Use,” which claims priority to U.S. Provisional Application No. 62/560,808, filed on Sep. 20, 2017 and titled, “Disinfecting Luer Cap and Method of Use,” and U.S. Provisional Application No. 62/451,298, filed on Jan. 27, 2017 and titled, “Disinfecting Caps for Open Luer Connectors,” all of which are hereby incorporated by reference in their entireties.

US Referenced Citations (245)
Number Name Date Kind
1744026 Baltzley Oct 1926 A
1868200 Freedman Jul 1932 A
2299037 Saueressig Oct 1942 A
2351804 Blum Jun 1944 A
2356969 Blum Aug 1944 A
2472921 Quimper Jun 1949 A
2994420 Fobias Aug 1961 A
3315830 Flynn Apr 1967 A
3431548 Busler Mar 1969 A
3446596 Salivar et al. May 1969 A
3976311 Spendlove Aug 1976 A
3987930 Fuson Oct 1976 A
4121727 Robbins et al. Oct 1978 A
4232677 Leibinsohn Nov 1980 A
4299330 Walter Nov 1981 A
4324239 Gordon et al. Apr 1982 A
4334551 Pfister Jun 1982 A
4340052 Dennehey et al. Jul 1982 A
4346703 Dennehey et al. Aug 1982 A
4354490 Rogers Oct 1982 A
4369781 Gilson et al. Jan 1983 A
4402691 Rosenthal et al. Sep 1983 A
4432764 Lopez Feb 1984 A
4432766 Bellotti et al. Feb 1984 A
4440207 Genatempo et al. Apr 1984 A
4450624 Collier May 1984 A
4572373 Johansson Feb 1986 A
4597758 Aalto et al. Jul 1986 A
4624664 Peluso et al. Nov 1986 A
4667837 Vitello et al. May 1987 A
4671306 Spector Jun 1987 A
4778447 Velde et al. Oct 1988 A
4798303 Arnold Jan 1989 A
4810241 Rogers Mar 1989 A
4838875 Somor Jun 1989 A
D303631 Demarest Sep 1989 S
D310542 Regnault Sep 1990 S
4991629 Ernesto et al. Feb 1991 A
5006114 Rogers et al. Apr 1991 A
5165559 Kusz Nov 1992 A
5184742 Decaprio et al. Feb 1993 A
D333788 Geschwender Mar 1993 S
5190534 Kendell Mar 1993 A
5195957 Tollini Mar 1993 A
5205821 Kruger et al. Apr 1993 A
5242425 White et al. Sep 1993 A
D340112 Zeman Oct 1993 S
D341227 Lang et al. Nov 1993 S
5269771 Thomas et al. Dec 1993 A
5385372 Utterberg Jan 1995 A
5439451 Collinson et al. Aug 1995 A
5445270 Dratz Aug 1995 A
5451113 Lund et al. Sep 1995 A
5466219 Lynn et al. Nov 1995 A
5492147 Challender et al. Feb 1996 A
5536258 Folden Jul 1996 A
5554135 Menyhay Sep 1996 A
5593055 Repp et al. Jan 1997 A
5599307 Pacher et al. Feb 1997 A
5620427 Werschmidt et al. Apr 1997 A
5624057 Lifshey Apr 1997 A
5674198 Leone Oct 1997 A
5694978 Heilmann et al. Dec 1997 A
5702017 Goncalves Dec 1997 A
5738663 Lopez Apr 1998 A
5792120 Menyhay Aug 1998 A
5833658 Levy et al. Nov 1998 A
5839715 Leinsing Nov 1998 A
5893841 Glickman Apr 1999 A
5894015 Rechtin Apr 1999 A
5951519 Utterberg Sep 1999 A
5954657 Rados Sep 1999 A
5954957 Chin-Loy et al. Sep 1999 A
5964978 Hirooka Oct 1999 A
6045539 Menyhay Apr 2000 A
6117105 Bresnaham et al. Sep 2000 A
6152913 Feith et al. Nov 2000 A
6171287 Lynn et al. Jan 2001 B1
D456668 Tse May 2002 S
D468015 Horppu Dec 2002 S
D470888 Kuboshima Feb 2003 S
6523686 Bae Feb 2003 B1
6695160 Culley et al. Feb 2004 B1
6753114 Jacobs et al. Jun 2004 B2
6932795 Lopez et al. Aug 2005 B2
6960191 Howlett et al. Nov 2005 B2
7014169 Newton et al. Mar 2006 B2
7040598 Raybuck May 2006 B2
7040669 Kenmotsu et al. May 2006 B2
7100796 Orr et al. Sep 2006 B1
7198611 Connell et al. Apr 2007 B2
D545964 Blanco Jul 2007 S
D547446 Racz et al. Jul 2007 S
D550355 Racz et al. Sep 2007 S
7282186 Lake, Jr. et al. Oct 2007 B2
7316669 Ranalleiia Jan 2008 B2
D573643 Brigham et al. Jul 2008 S
7452592 Cowton Nov 2008 B2
D607325 Rogers et al. Jan 2010 S
7762524 Cawthon et al. Jul 2010 B2
7762988 Vitello Jul 2010 B1
7763006 Tennican Jul 2010 B2
7780794 Rogers et al. Aug 2010 B2
D632574 Huntington et al. Feb 2011 S
7922701 Buchman Apr 2011 B2
D639421 Sano et al. Jun 2011 S
7985302 Rogers et al. Jul 2011 B2
8167847 Anderson et al. May 2012 B2
8172825 Solomon et al. May 2012 B2
8177761 Howlett et al. May 2012 B2
8197749 Howlett et al. Jun 2012 B2
8231587 Solomon et al. Jul 2012 B2
8231602 Anderson et al. Jul 2012 B2
8273303 Ferlic et al. Sep 2012 B2
8328767 Solomon et al. Dec 2012 B2
8343112 Solomon et al. Jan 2013 B2
8419713 Solomon et al. Apr 2013 B1
8523830 Solomon et al. Sep 2013 B2
8523831 Solomon et al. Sep 2013 B2
8641681 Solomon et al. Feb 2014 B2
8647308 Solomon et al. Feb 2014 B2
8647326 Solomon et al. Feb 2014 B2
8740864 Hoang Jun 2014 B2
8784388 Charles et al. Jul 2014 B2
8808637 Ferlic Aug 2014 B2
8961475 Solomon et al. Feb 2015 B2
9079692 Solomon et al. Jul 2015 B2
9101750 Solomon et al. Aug 2015 B2
9114915 Solomon et al. Aug 2015 B2
9242084 Solomon et al. Jan 2016 B2
9283369 Ma et al. Mar 2016 B2
9352140 Kerr et al. May 2016 B2
10975208 Pekala et al. Apr 2021 B2
20020093192 Matkovich Jul 2002 A1
20030140441 Stafford Jul 2003 A1
20030153865 Connell et al. Aug 2003 A1
20030181849 Castellanos Sep 2003 A1
20030198502 Maloney et al. Oct 2003 A1
20040010909 Emanuel et al. Jan 2004 A1
20040039341 Ranalletta Feb 2004 A1
20040195136 Young et al. Oct 2004 A1
20040201216 Segal et al. Oct 2004 A1
20040214316 O'Connell Oct 2004 A1
20040258560 Lake, Jr. et al. Dec 2004 A1
20050033267 Decaria Feb 2005 A1
20050038397 Newton et al. Feb 2005 A1
20050124970 Kunin et al. Jun 2005 A1
20050147524 Bousquet Jul 2005 A1
20050183971 Petricca Aug 2005 A1
20050203460 Kim Sep 2005 A1
20050245883 Baldwin Nov 2005 A1
20050265773 De Laforcade Dec 2005 A1
20050266714 Higgins et al. Dec 2005 A1
20060030827 Raulerson et al. Feb 2006 A1
20060177250 Nakagaki Aug 2006 A1
20070112333 Hoang et al. May 2007 A1
20070202177 Hoang Aug 2007 A1
20070282280 Tennican Dec 2007 A1
20070287989 Crawford et al. Dec 2007 A1
20070292750 Beard Dec 2007 A1
20070293818 Stout et al. Dec 2007 A1
20070293822 Crawford et al. Dec 2007 A1
20080019889 Rogers et al. Jan 2008 A1
20080021381 Lurvey et al. Jan 2008 A1
20080027399 Harding et al. Jan 2008 A1
20080033371 Updefraff et al. Feb 2008 A1
20080038167 Lynn Feb 2008 A1
20080039803 Lynn Feb 2008 A1
20080097407 Plishka Feb 2008 A1
20080086091 Anderson et al. Apr 2008 A1
20080095680 Steffens et al. Apr 2008 A1
20080105704 Pritchard May 2008 A1
20080107564 Sternberg et al. May 2008 A1
20080132880 Buchman Jun 2008 A1
20080147047 Davis et al. Jun 2008 A1
20080177250 Howlett et al. Jul 2008 A1
20080190485 Guala Aug 2008 A1
20080221552 Leonard Sep 2008 A1
20080235888 Vaillancourt et al. Oct 2008 A1
20090008393 Howlett et al. Jan 2009 A1
20090062766 Howlett et al. Mar 2009 A1
20090099529 Anderson et al. Apr 2009 A1
20090149819 Chelak Jun 2009 A1
20090205151 Fisher et al. Aug 2009 A1
20090287160 Sudo et al. Nov 2009 A1
20100003067 Shaw et al. Jan 2010 A1
20100047123 Solomon et al. Feb 2010 A1
20100049170 Solomon et al. Feb 2010 A1
20100063482 Mansour et al. Mar 2010 A1
20100058201 Hattangadi et al. Apr 2010 A1
20100100056 Cawthon et al. Apr 2010 A1
20100242993 Hoang et al. Sep 2010 A1
20100285348 Murata et al. Nov 2010 A1
20100306938 Rogers et al. Dec 2010 A1
20100313366 Rogers et al. Dec 2010 A1
20110044850 Solomon et al. Feb 2011 A1
20110054440 Lewis Mar 2011 A1
20110064512 Shaw et al. Mar 2011 A1
20110064515 Ruckey et al. Mar 2011 A1
20110165020 Truggvason Jul 2011 A1
20110198935 Hinman et al. Aug 2011 A1
20110213341 Solomon et al. Sep 2011 A1
20110217212 Solomon et al. Sep 2011 A1
20110232020 Rogers et al. Sep 2011 A1
20110265825 Rogers et al. Nov 2011 A1
20110277788 Rogers et al. Nov 2011 A1
20110290754 Taber et al. Dec 2011 A1
20110314619 Schweikert Dec 2011 A1
20120016318 Hoang et al. Jan 2012 A1
20120028104 Brant et al. Feb 2012 A1
20120039764 Solomon Feb 2012 A1
20120039765 Solomon Feb 2012 A1
20120082977 Rajagopal et al. Apr 2012 A1
20120145468 Ekala et al. Jun 2012 A1
20120164513 Peng et al. Jun 2012 A1
20120216359 Rogers et al. Aug 2012 A1
20120281444 Dent Nov 2012 A1
20120326516 Gurunathan et al. Dec 2012 A1
20130019421 Rogers et al. Jan 2013 A1
20130072908 Solomon et al. Mar 2013 A1
20130171030 Ferlic et al. Jul 2013 A1
20130197485 Gardner et al. Aug 2013 A1
20130224555 Hong et al. Aug 2013 A1
20130234520 Dierksheide et al. Sep 2013 A1
20130299445 Cerracchio Nov 2013 A1
20140001182 Wood et al. Jan 2014 A1
20140010481 Last et al. Jan 2014 A1
20140135739 Solomon et al. May 2014 A1
20140227144 Liu et al. Aug 2014 A1
20140360968 Barth Dec 2014 A1
20150217106 Banik et al. Aug 2015 A1
20150229131 Gerhardinger Aug 2015 A1
20150231384 Ma et al. Aug 2015 A1
20150273199 Adams et al. Oct 2015 A1
20150374968 Solomon et al. Dec 2015 A1
20160028067 Pekala et al. Jan 2016 A1
20160038701 White et al. Feb 2016 A1
20160045629 Gardner et al. Feb 2016 A1
20160106968 Solomon et al. Apr 2016 A1
20160236852 Albrecht Aug 2016 A1
20170033564 Lin et al. Feb 2017 A1
20170245618 Chen et al. Aug 2017 A1
20190099593 Avula et al. Apr 2019 A1
20190209781 Solomon et al. Jul 2019 A1
20190386274 Wood et al. Dec 2019 A1
Foreign Referenced Citations (28)
Number Date Country
104157819 Nov 2014 CN
205549223 Sep 2016 CN
0084695 Aug 1983 EP
0229789 Jul 1987 EP
0229786 Mar 1990 EP
0462355 Dec 1991 EP
64002760 Jan 1989 JP
1020120057560 Jun 2012 KR
1020150131300 Nov 2015 KR
2002089899 Nov 2002 WO
2004035245 Apr 2004 WO
2006099306 Sep 2006 WO
2007097985 Aug 2007 WO
2008089196 Jul 2008 WO
2008100950 Aug 2008 WO
2010002808 Jan 2010 WO
2010141508 Dec 2010 WO
2011141508 Dec 2010 WO
2011053924 May 2011 WO
2011066565 Jun 2011 WO
2011066586 Jun 2011 WO
2011147508 Dec 2011 WO
2013184716 Dec 2013 WO
2014145849 Sep 2014 WO
2015174953 Nov 2015 WO
2016031466 Mar 2016 WO
2017158555 Sep 2017 WO
2017160892 Sep 2017 WO
Non-Patent Literature Citations (84)
Entry
Office Action dated Oct. 14, 2020 for U.S. Appl. No. 16/150,966.
European Search Report dated Jun. 28, 2021 for EP18865254.9.
Baxa Corporation Launches PadLock Set Saver for IV Safety press release, 2 pages, available at http://www.pr.com/press—release/55432, Oct. 10. 2007.
Baxa Corporation Padlock catalog, 3 pages, copyright 2009, available at http://www.baxa.com/SearchResults/ProductDetail/?id=6452BFB9-3048-7B87-701697FB93902BA6.
Baxa Corporation Padlock Microbial Testing Technical Paper, copyright 2007, 4 pages, available at http://www.baxa.com/resources/docs/technicalPapers/PadLockMicrobialChallengeTechPaper.pdf.
Baxa Corporation PadLock Set Saver Specifications and Instructions for Use, copyright 2007, 2 pages, available at http://www.baxa.com/resources/docs/5300103905C.pdf.
BD Q-Syte Luer Access Split Septum product brochure, 4 pages, available at http://www.bd.com/infusion/pdfs/D16333.pdf. ,Nov. 2008.
Braun product catalog, 2pages. ,Aug. 2008.
Curos Port Protector product brochure, 2 pages, available at http://www.iveramed.com/clocs/Curos%20Brochure-FINAL.pdf. ,Nov. 2008.
Hospira Male/Female Sterile Cap product packaging insert and brochure, 2 pages. ,Aug. 2004.
Kippmed Vented Non-Vented Female Luer Lock Caps, The KippGroup, ,Jan. 1995 ,2 pgs.
Tego Connector product brochure, 2 pages, available at http://www.icumed.com/Docs-Tego/M1-1148%20TEG0%20Folder%20Brochure%20Rev.3.pdf. ,Nov. 2008.
Unomedical Medical Products catalog, 2 pages, available at http://www.unomedical.net/au/section05/section10/LocalSSI/..%5C..%5Cpdf%5Cmedical.pdf ,Jan. 2006.
European Search Report dated Mar. 6, 2012 for EP08727689.5.
European Search Report dated Mar. 25, 2020 for EP15808498.8.
European Search Report dated Jun. 13, 2019 for EP16866954.7.
European Search Report dated Jun. 20, 2017 for EP10827614.8.
International Search Report and the Written Opinion dated Jan. 26, 2011 for PCT/US2010/058404.
International Search Report and Written Opinion dated Jan. 6, 2011 for PCT/US2010/054995.
International Search Report and Written Opinion dated Jan. 24, 2019 for PCT/US2018/054202.
International Search Report and Written Opinion dated Feb. 1, 2017 for PCT/US2016/062061.
International Search Report and Written Opinion dated Feb. 7, 2011 for PCT/US2010/058453.
International Search Report and Written Opinion dated Jun. 22, 2018 for PCT/US2018/014237.
International Search Report and Written Opinion dated Aug. 1, 2008 for PCT/US2008/051087.
International Search Report with Written Opinion dated Aug. 31, 2009 for PCT/US2009/049094.
Notice of Allowance dated Jun. 7, 2017 for U.S. Appl. No. 14/162,207.
Notice of Allowance dated Sep. 1, 2017 for U.S. Appl. No. 14/162,207.
Buchman, et al., A New Central Venous Catheter Cap: Decreased Microbial Growth and Risk for Catheter-Related Bloodstream Infection, The Journal of Vascular Access ,2009 ,11-21.
Maki, et al., ln Vitro Studies of a Novel Antimicrobial Luer-Activated Needleless Connector for Prevention of Catheter-Related Blookstream Infection, Clinical Infection Diseases, vol. 50, Issue 12 ,Jun. 15, 2010 ,1580-1587.
Menyhay, et al., Disinfection of Needleless Catheter Connecors and Access Ports with Alcohol May Not Prevent Microbial Entry: The Promise of a Novel Antiseptic-Barrier Cap, Infection control and Hospital Epidemiology, vol. 27 No. 1 ,Jan. 2006 ,23-27.
Stoker, et al., One Less Problem, Safe Practrices when Administering IV Therapy, Managing Infection Control, 4 pgs ,Jun. 2008.
European Search Report dated Jun. 9, 2020 for EP18744486.4.
Notice of Allowance dated Apr. 6, 2021 for U.S. Appl. No. 16/150,966.
Notice of Allowance dated Jan. 11, 2023 for U.S. Appl. No. 14/797,533.
Dictionary.com Unabridged, Opposite, Jan. 5, 2016, Random House, Inc.
European Search Report dated Aug. 28, 2013 for EP13175144.8.
International Search Report and Written Opinion dated Jul. 21, 2009 for PCT/US2008/051087.
Notice of Allowance dated Sep. 17, 2018 for U.S. Appl. No. 14/845,004.
Notice of Allowance dated Oct. 25, 2018 for U.S. Appl. No. 14/947,341.
Notice of Allowance dated Nov. 9, 2018 for U.S. Appl. No. 15/203,002.
Notice of Allowance dated Dec. 19, 2019 for U.S. Appl. No. 15/979,213.
Office Action dated Jan. 3, 2018 for U.S. Appl. No. 13/935,921.
Office Action dated Jan. 12, 2016 for U.S. Appl. No. 13/935,921.
Office Action dated Jan. 27, 2010 for U. S. U.S. Appl. No. 12/014,388.
Office Action dated Feb. 14, 2017 for U.S. Appl. No. 13/935,921.
Office Action dated Feb. 27, 2018 for U.S. Appl. No. 14/978,925.
Office Action dated Mar. 4, 2021 for U.S. Appl. No. 14/797,533.
Office Action dated Mar. 8, 2021 for U.S. Appl. No. 16/235,584.
Office Action dated Mar. 27, 2019 for U.S. Appl. No. 14/797,533.
Office Action dated Apr. 4, 2018 for U.S. Appl. No. 14/845,004.
Office Action dated Apr. 22, 2011 for U.S. Appl. No. 12/164,310.
Office Action dated Apr. 26, 2018 for U.S. Appl. No. 14/797,533.
Office Action dated May 5, 2009 for U.S. Appl. No. 12/014,388.
Office Action dated May 25, 2018 for U.S. Appl. No. 15/203,002.
Office Action dated May 27, 2022 for U.S. Appl. No. 16/081,691.
Office Action dated Jun. 3, 2019 for U.S. Appl. No. 14/978,925.
Office Action dated Jun. 7, 2018 for U.S. Appl. No. 14/947,341.
Office Action dated Jun. 9, 2011 for U.S. Appl. No. 12/171,997.
Office Action dated Jun. 18, 2021 for U.S. Appl. No. 16/235,584.
Office Action dated Jun. 21, 2010 for U.S. Appl. No. 12/014,388.
Office Action dated Jun. 25, 2020 for U.S. Appl. No. 16/235,584.
Office Action dated Jul. 17, 2019 for U.S. Appl. No. 14/797,533.
Office Action dated Jul. 23, 2020 for U.S. Appl. No. 14/797,533.
Office Action dated Jul. 28, 2015 for U.S. Appl. No. 13/935,921.
Office Action dated Aug. 16, 2010 for U.S. Appl. No. 12/164,310.
Office Action dated Aug. 21, 2017 for U.S. Appl. No. 13/935,921.
Office Action dated Aug. 22, 2022 for U.S. Appl. No. 14/797,533.
Office Action dated Aug. 30, 2019 for U.S. Appl. No. 15/979,213.
Office Action dated Sep. 14, 2018 for U.S. Appl. No. 14/978,925.
Office Action dated Sep. 27, 2016 for U.S. Appl. No. 13/935,921.
Office Action dated Oct. 20, 2017 for U.S. Appl. No. 15/203,002.
Office Action dated Nov. 17, 2017 for U.S. Appl. No. 14/845,004.
Office Action dated Nov. 26, 2021 for U.S. Appl. No. 14/797,533.
Office Action dated Nov. 29, 2018 for U.S. Appl. No. 14/797,533.
Office Action dated Dec. 23, 2010 for U.S. Appl. No. 12/014,388.
“Curos Port Protector”, web page from http://www.iveramed.com/, Jul. 11, 2008.
“Kippmed Vented Non-Vented Female Luer Lock Caps”, The KippGroup,, Jan. 1, 1995, 2 pgs.
Buchman , et al., “A New Central Venous Catheter Cap: Decreased Microbial Growth and Risk for Catheter-Related Bloodstream Infection”, The Journal of Vascular Access, Jan. 1, 2009, 11-21.
PCT/US2017/022382 , International Preliminary Report on Patentability, Sep. 27, 2018, 10 pages.
International Search Report and Written Opinion dated Feb. 23, 2021 for PCT/IB2020/060662.
International Search Report and Written Opinion dated Jul. 1, 2019 for PCT/US2019/020625.
International Search Report and Written Opinion dated Jul. 19, 2017 for PCT/US2017/022382.
Office Action dated Apr. 17, 2020 for U.S. Appl. No. 16/081,691.
Second Written Opinion dated Feb. 11, 2021 for PCT/IB2020/060662.
Related Publications (1)
Number Date Country
20210016077 A1 Jan 2021 US
Provisional Applications (2)
Number Date Country
62560808 Sep 2017 US
62451298 Jan 2017 US
Continuations (1)
Number Date Country
Parent 15874505 Jan 2018 US
Child 16836678 US